Julio Rosenstock Selected Research

Julio Rosenstock Research Topics

Disease

185	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2002
56	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2003
50	Body Weight (Weight, Body) 11/2022 - 02/2006
33	Weight Loss (Weight Reduction) 11/2022 - 05/2005
23	Weight Gain 06/2021 - 06/2004
18	Nausea 10/2021 - 02/2006
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2005
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2015
12	Overweight 11/2022 - 11/2003
12	Vomiting 10/2021 - 01/2011
12	Infections 01/2019 - 06/2012
11	Heart Failure 08/2022 - 07/2012
9	Obesity 11/2022 - 03/2005
8	Kidney Diseases (Kidney Disease) 01/2022 - 09/2015
8	Myocardial Infarction 10/2021 - 11/2016
8	Stroke (Strokes) 10/2021 - 11/2016
8	Hyperglycemia 01/2018 - 07/2010
7	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 03/2015
6	Pancreatitis 10/2021 - 01/2017
5	Prediabetic State (Prediabetes) 08/2022 - 07/2010
5	Insulin Resistance 01/2021 - 10/2006
5	Diarrhea 01/2021 - 01/2011
5	Albuminuria 04/2020 - 09/2015
5	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 06/2012
4	Chronic Renal Insufficiency 12/2021 - 01/2019
4	Body Weight Changes 06/2021 - 02/2006
4	Injection Site Reaction 11/2020 - 03/2013
4	Diabetes Mellitus 01/2020 - 05/2002
4	Edema (Dropsy) 07/2012 - 03/2006
3	Pain (Aches) 11/2017 - 08/2004
3	Neuralgia (Stump Neuralgia) 11/2017 - 09/2008
3	Dizziness (Lightheadedness) 12/2014 - 08/2004
3	Peripheral Nervous System Diseases (PNS Diseases) 02/2013 - 08/2004
2	Proteinuria 09/2021 - 01/2021
2	Constipation 01/2021 - 01/2011
2	Cognitive Dysfunction 11/2020 - 10/2019
2	Hypersensitivity (Allergy) 11/2020 - 03/2013

Drug/Important Bio-Agent (IBA)

75	Insulin (Novolin)FDA Link 01/2022 - 04/2002
61	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2003
57	Metformin (Glucophage)FDA LinkGeneric 11/2020 - 05/2005
48	Insulin Glargine (Lantus)FDA Link 01/2022 - 11/2003
23	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 10/2009
19	lixisenatideIBA 01/2022 - 09/2013
19	LinagliptinIBA 09/2021 - 08/2012
18	Exenatide (Byetta)FDA Link 10/2021 - 05/2005
18	Hypoglycemic Agents (Hypoglycemics)IBA 06/2021 - 10/2004
17	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 09/2002
16	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 07/2009
14	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 07/2012
14	Sodium-Glucose Transport ProteinsIBA 01/2021 - 06/2012
14	Pharmaceutical PreparationsIBA 01/2019 - 02/2006
13	semaglutideIBA 11/2022 - 11/2016
12	Liraglutide FDA Link 11/2022 - 07/2009
11	empagliflozinIBA 08/2022 - 07/2014
11	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 04/2014
11	LipidsIBA 03/2012 - 03/2005
9	CreatinineIBA 01/2022 - 06/2012
8	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2019
8	glimepiride (Amarel)FDA LinkGeneric 01/2021 - 08/2012
8	dapagliflozinIBA 01/2020 - 07/2012
7	InsulinsIBA 01/2022 - 04/2012
7	AlbuminsIBA 01/2022 - 09/2015
7	SodiumIBA 01/2022 - 07/2012
7	Blood Glucose (Blood Sugar)IBA 01/2021 - 03/2010
7	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2020 - 01/2008
7	Pioglitazone (Actos)FDA Link 11/2019 - 10/2006
7	saxagliptin FDA Link 01/2019 - 11/2010
6	LDL CholesterolIBA 01/2022 - 08/2008
6	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 12/2021 - 07/2013
6	rGLP-1 proteinIBA 11/2021 - 10/2009
6	insulin degludecIBA 01/2021 - 03/2011
6	CanagliflozinIBA 01/2019 - 06/2012
6	Colesevelam Hydrochloride (Welchol)FDA Link 07/2012 - 08/2008
5	efpeglenatideIBA 01/2022 - 01/2019
5	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 10/2006
5	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2018 - 09/2002
4	Protamines (Protamine Sulfate)FDA Link 06/2021 - 10/2004
4	IncretinsIBA 01/2021 - 05/2005
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 07/2010
4	LY2605541IBA 01/2014 - 11/2012
4	Exubera FDA Link 03/2010 - 06/2004
4	PowdersIBA 03/2010 - 02/2007
3	Insulin Aspart (NovoLog)FDA Link 06/2021 - 10/2004
3	insulin aspart protamine drug combination 30:70 insulin aspartIBA 06/2021 - 10/2004
3	SuspensionsIBA 10/2020 - 01/2008
3	Insulin Lispro (Humalog)FDA Link 10/2020 - 01/2008
3	insulin glulisine FDA Link 08/2016 - 10/2004
3	Short-Acting InsulinIBA 01/2016 - 09/2013
3	Isophane Insulin (NPH Insulin)FDA Link 11/2012 - 11/2004
3	oxidized low density lipoproteinIBA 07/2012 - 07/2010
3	VildagliptinIBA 01/2008 - 02/2007
2	KetonesIBA 01/2022 - 12/2018
2	tirzepatideIBA 10/2021 - 01/2021
2	Peptides (Polypeptides)IBA 10/2021 - 01/2021
2	insulin icodecIBA 01/2021 - 11/2020

Therapy/Procedure

71	Therapeutics 08/2022 - 09/2002
58	Glycemic Control 01/2022 - 04/2002
15	Injections 01/2022 - 04/2002
4	Subcutaneous Injections 01/2021 - 04/2002
2	Aftercare (After-Treatment) 01/2022 - 12/2011